Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Synthesis of some impurities and/or degradation products of atorvastatin

Jan Stach, Jaroslav Havlíček, Lukáš Plaček, Stanislav Rádl

Language English Country Czech Republic

E-resources Online

NLK ProQuest Central from 2005-01-01 to 2011

Synthesis of some impurities and/or degradation products of atorvastatin, calcium (3R,5R)-7- [2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)pyrrol-1-yl]-3,5-dihydroxyheptanoate, is described. These include its desfluoro analog, the corresponding (3S,5S)- and (3S,5R)-epimers, atorvastatin lactone, and some other potential impurities. The synthesized compounds as well as the corresponding intermediates were characterized by 1H NMR, 13C NMR and MS.

Bibliography, etc.

Lit.: 12

000      
02100naa 2200409 a 4500
001      
bmc07505894
003      
CZ-PrNML
005      
20130331191452.0
008      
080630s2008 xr e eng||
009      
AR
024    7_
$2 doi $a 10.1135/cccc20080229
040    __
$a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Stach, Jan, $d 1972- $7 xx0141349
245    10
$a Synthesis of some impurities and/or degradation products of atorvastatin / $c Jan Stach, Jaroslav Havlíček, Lukáš Plaček, Stanislav Rádl
314    __
$a Zentiva, Praha 10
504    __
$a Lit.: 12
520    9_
$a Synthesis of some impurities and/or degradation products of atorvastatin, calcium (3R,5R)-7- [2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)pyrrol-1-yl]-3,5-dihydroxyheptanoate, is described. These include its desfluoro analog, the corresponding (3S,5S)- and (3S,5R)-epimers, atorvastatin lactone, and some other potential impurities. The synthesized compounds as well as the corresponding intermediates were characterized by 1H NMR, 13C NMR and MS.
650    _2
$a pyrroly $x chemická syntéza $7 D011758
650    _2
$a kyseliny heptylové $x chemická syntéza $7 D006538
650    _2
$a statiny $x chemická syntéza $7 D019161
650    _2
$a financování organizované $7 D005381
650    _2
$a racionální návrh léčiv $7 D015195
653    00
$a Lipitor
653    00
$a Sortis
700    1_
$a Havlíček, Jaroslav, $d 1961- $7 jo2003190657
700    1_
$a Plaček, Lukáš. $7 _BN004562
700    1_
$a Rádl, Stanislav, $7 jx20061013029 $d 1951-
773    0_
$w MED00010973 $t Collection of Czechoslovak chemical communications $g Roč. 73, č. 2 (2008), s. 229-246 $x 0010-0765
910    __
$a ABA008 $b A 1006 $c 394 $y 9
990    __
$a 20080625111328 $b ABA008
991    __
$a 20130331191735 $b ABA008
999    __
$a ok $b bmc $g 621516 $s 473949
BAS    __
$a 3
BMC    __
$a 2008 $b 73 $c 2 $d 229-246 $i 0010-0765 $m Collection of Czechoslovak Chemical Communications $x MED00010973
LZP    __
$a 2008-16/vtmv

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...